Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 96.47 USD 0.34% Market Closed
Market Cap: 17.6B USD
Have any thoughts about
Insmed Inc?
Write Note

Wall Street
Price Targets

INSM Price Targets Summary
Insmed Inc

Wall Street analysts forecast INSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INSM is 113.95 USD with a low forecast of 93.03 USD and a high forecast of 131.25 USD.

Lowest
Price Target
93.03 USD
4% Downside
Average
Price Target
113.95 USD
18% Upside
Highest
Price Target
131.25 USD
36% Upside
Insmed Inc Competitors:
Price Targets
OCX
OncoCyte Corp
75% Upside
005690
Pharmicell Co Ltd
37% Upside
BBIO
BridgeBio Pharma Inc
33% Upside
IMNM
Immunome Inc
181% Upside
688520
Sinocelltech Group Ltd
27% Downside
TLX
Telix Pharmaceuticals Ltd
39% Upside
COV
Covalon Technologies Ltd
47% Upside
INCY
Incyte Corp
13% Upside

Revenue
Forecast

Revenue Estimate
Insmed Inc

The compound annual growth rate of Insmed Inc's revenue for the next 3 years is 74%.

N/A
Past Growth
74%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Insmed Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Insmed Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INSM's stock price target?
Price Target
113.95 USD

According to Wall Street analysts, the average 1-year price target for INSM is 113.95 USD with a low forecast of 93.03 USD and a high forecast of 131.25 USD.

What is Insmed Inc's Revenue forecast?
Projected CAGR
74%

The compound annual growth rate of Insmed Inc's revenue for the next 3 years is 74%.

Back to Top